Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Variant : CV74565 (GRCh38/hg38 1p32.2-31.1(chr1:57350574-71325924)x1) Homo sapiens

Symbol: CV74565
Name: GRCh38/hg38 1p32.2-31.1(chr1:57350574-71325924)x1
Condition: Global developmental delay [RCV000053841]|See cases [RCV000053841]
Clinical Significance: pathogenic
Last Evaluated: 08/12/2011
Review Status: classified by single submitter|criteria provided, single submitter|no assertion criteria provided
Related Genes: AK4   ALG6   ANGPTL3   ANKRD13C   ATG4C   C1orf141   C1orf87   CACHD1   CTH   CYP2J2   DAB1   DAB1-AS1   DEPDC1   DEPDC1-AS1   DIRAS3   DLEU2L   DNAJC6   DOCK7   EFCAB7   FGGY   FOXD3   FOXD3-AS1   GADD45A   GNG12   GNG12-AS1   HHLA3   HHLA3-AS1   HOOK1   IL12RB2   IL23R   INSL5   ITGB3BP   JAK1   JUN   KANK4   L1TD1   LEPR   LEPROT   LINC00466   LINC01135   LINC01358   LINC01359   LINC01707   LINC01739   LINC01748   LINC01758   LINC01788   LINC02777   LINC02791   LRRC40   LRRC7   LRRC7-AS1   MIER1   MIR101-1   MIR12132   MIR1262   MIR186   MIR3116-1   MIR3116-2   MIR3117   MIR3671   MIR4711   MIR4794   MIR6068   MYSM1   NFIA   NFIA-AS1   NFIA-AS2   OMA1   PATJ   PDE4B   PDE4B-AS1   PGM1   PTGER3   RAVER2   ROR1   ROR1-AS1   RPE65   SERBP1   SGIP1   SLC35D1   SRSF11   TACSTD2   TCTEX1D1   TM2D1   UBE2U   USP1   WDR78   WLS   ZRANB2   ZRANB2-AS1   ZRANB2-AS2  
Variant Type: copy number loss (SO:0001743)
Evidence: clinical testing
HGVS Name(s): NC_000001.11:g.(?_57350574)_(71325924_?)del
Human AssemblyChrPosition (strand)Source
GRCh38157,350,574 - 71,325,924CLINVAR
GRCh37157,816,246 - 71,791,607CLINVAR
Build 36157,588,834 - 71,564,195CLINVAR
Cytogenetic Map11p32.2-31.1CLINVAR
Prevalence: mental retardation is caused by aberrant copy numbers of subtelomeric regions in 3-8% of all cases.

References - uncurated

Additional Information

External Database Links
CRRD Object Information
CRRD ID: 8620756
Created: 2014-05-13
Species: Homo sapiens
Last Modified: 2019-11-05
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.